beta-Amyloid-induced IL-1 beta release from an activated human monocyte cell line is calcium- and G-protein-dependent.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Mechanisms of Ageing and Development

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9147372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunodetection of the amyloid P component in Alzheimer's disease

  2004cited by this paper
• beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes.

  1996cited by this paper
• The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide*

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?

  1995cited by this paper
• Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

  1995cited by this paper
• Complement and cytokine gene expression in cultured microglia derived from postmortem human brains

  1995cited by this paper
• Glial cytokines in Alzheimer's disease: review and pathogenic implications.

  1995cited by this paper
• Nonsteroidal anti-inflammatory drugs in Alzheimer's disease

  1995cited by this paper
• Alzheimer's disease and rheumatoid arthritis.

  1994cited by this paper
• Inverse association of anti‐inflammatory treatments and Alzheimer's disease

  1994cited by this paper
• The molecular biology of leukocyte chemoattractant receptors.

  1994cited by this paper
• Neuroimmune Mechanisms in Alzheimer Disease Pathogenesis

  1994cited by this paper
• Towards a better aspirin

  1994cited by this paper
• Nonsteroidal antiinflammatory drug use in Alzheimer's disease.

  1994cited by this paper
• Activation of macrophages by Alzheimer beta amyloid peptide.

  1994cited by this paper
• Clinical trial of indomethacin in Alzheimer's disease

  1993cited by this paper
• Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products.

  1993cited by this paper
• Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

  1993cited by this paper
• Alpha 2-macroglobulin and subacute-phase responses in Alzheimer's disease.

  1993cited by this paper
• Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

  1992cited by this paper
• A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.

  1992cited by this paper
• G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes.

  1992cited by this paper
• Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

  1992cited by this paper
• Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease.

  1992cited by this paper
• A case‐control study of Alzheimer's disease in China

  1992cited by this paper
• Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.

  1992cited by this paper
• The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes.

  1992cited by this paper
• Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein.

  1991cited by this paper
• Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

  1991cited by this paper
• Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.

  1991cited by this paper
• Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

  1991cited by this paper
• Chemotaxis by a CNS macrophage, the microglia

  1990cited by this paper
• Anti-inflammatory drugs and Alzheimer disease.

  1990cited by this paper
• A case‐control study of Alzheimer's disease

  1990cited by this paper
• Distribution of the protease inhibitor alpha 1-antichymotrypsin in cerebral and systemic amyloid.

  1990cited by this paper
• A case‐control study of Alzheimer's disease in Australia

  1990cited by this paper
• Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Rheumatoid arthritis and senile dementia of the Alzheimer's type.

  1989cited by this paper
• Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

  1989cited by this paper
• A commercially available serum-free medium appropriate for studies of macrophage functions in vitro.

  1988cited by this paper
• ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)

  1980cited by this paper

• Microglia Signaling in Health and Disease - Implications in Sex-Specific Brain Development and Plasticity.

  2024cites this paper
• Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.

  2022cites this paper
• Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition

  2020cites this paper
• Beneficial Effects of Fingolimod in Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Potential

  2019cites this paper
• Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model

  2016cites this paper
• Attenuation of microglial activation in a mouse model of Alzheimer’s disease via NFAT inhibition

  2015cites this paper
• Amyloid Precursor Protein Mediated Changes in Intestinal Epithelial Phenotype In Vitro

  2015cites this paper
• Role of N-terminal residues in Aβ interactions with integrin receptor and cell surface.

  2014cites this paper
• Endogenous aggregates of amyloidogenic cystatin C variant are removed by THP-1 cells in vitro and induce differentiation and a proinflammatory response.

  2013cites this paper
• Calcium influx blocked by SK&F 96365 modulates the LPS plus IFN-γ-induced inflammatory response in murine peritoneal macrophages.

  2012cites this paper
• Amyloid β Peptides Trigger CD47-Dependent Mast Cell Secretory and Phagocytic Responses

  2009cites this paper
• Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

  2006cites this paper
• Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in alzheimer disease

  2005cites this paper
• Beta-Amyloid₁₋₄₂- induced intracellular signaling pathways, functional responses and modulation by 4-aminopyridine in microglia

  2005cites this paper
• Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells.

  2005cites this paper
• The immune modulator FTY720 targets sphingosine–kinase‐dependent migration of human monocytes in response to amyloid beta‐protein and its precursor

  2004cites this paper
• A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation

  2003influential citation
• Potential role of the formyl peptide receptor‐like 1 (FPRL1) in inflammatory aspects of Alzheimer’s disease

  2002cites this paper
• Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

  2002cites this paper
• Receptors for chemotactic formyl peptides as pharmacological targets.

  2002cites this paper
• Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures.

  2002cites this paper
• β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

  2001influential citation
• The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

  2001cites this paper
• beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

  2001influential citation
• Microglia and the pathogenesis of spongiform encephalopathies.

  2001cites this paper
• Amyloid β42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1

  2001cites this paper
• Pleiotropic roles of formyl peptide receptors.

  2001cites this paper
• Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

  2001cites this paper
• Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.

  2001cites this paper
• Amyloid-β Induces Chemotaxis and Oxidant Stress by Acting at Formylpeptide Receptor 2, a G Protein-coupled Receptor Expressed in Phagocytes and Brain*

  2001cites this paper
• Chemokines and Alzheimer's disease.

  2001cites this paper
• Gangliosides inhibit the release of interleukin-1beta in amyloid beta-protein-treated human monocytic cells.

  2001cites this paper
• Gangliosides inhibit the release of interleukin-1β in amyloid β-protein-treated human monocytic cells

  2001cites this paper
• Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro

  2001cites this paper
• The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes: implications for Alzheimer's disease.

  2000cites this paper
• Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta.

  2000cites this paper
• Factors influencing the processing and function of the amyloid beta precursor protein--a potential therapeutic target in Alzheimer's disease?

  2000cites this paper
• Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

  2000cites this paper
• Human Amylin Stimulates Inflammatory Cytokine Secretion from Human Glioma Cells

  2000cites this paper
• Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent.

  1999cites this paper
• Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of β-Amyloid and Prion Proteins

  1999influential citation
• Differential regulation of major histocompatibility complex class II expression and nitric oxide release by beta-amyloid in rat astrocyte and microglia.

  1999cites this paper
• Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease.

  1999influential citation
• The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.

  1999cites this paper
• A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.

  1999cites this paper
• Microglia and Alzheimer's disease.

  1999cites this paper